Unknown

Dataset Information

0

Superior outcome of upfront allogeneic hematopoietic cell transplantation versus hypomethylating agent induction in myelodysplastic syndrome.

ABSTRACT:

SUBMITTER: Schroeder JC 

PROVIDER: S-EPMC11368806 | biostudies-literature | 2024 Sep

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Superior outcome of upfront allogeneic hematopoietic cell transplantation versus hypomethylating agent induction in myelodysplastic syndrome.

Schroeder Jan Christian JC   Mix Lucas L   Faustmann Philipp P   Weller Jan Frederic JF   Fehn Adrian A   Phely Laurent L   Riedel Andreas A   Vogel Wichard W   Faul Christoph C   Lengerke Claudia C   Bethge Wolfgang Andreas WA  

Bone marrow transplantation 20240709 9

Similar Datasets

Unknown Evaluation of induction chemotherapies after hypomethylating agent failure in myelodysplastic syndromes and acute myeloid leukemia.
| S-EPMC6113613 | biostudies-literature
Unknown Individual outcome prediction for myelodysplastic syndrome (MDS) and secondary acute myeloid leukemia from MDS after allogeneic hematopoietic cell transplantation.
| S-EPMC7116654 | biostudies-literature
Unknown Allogeneic Hematopoietic Stem Cell Transplantation Is Underutilized in Older Patients with Myelodysplastic Syndromes.
| S-EPMC7386429 | biostudies-literature
Unknown Childhood myelodysplastic syndromes: Is cytoreductive therapy useful before allogeneic hematopoietic stem cell transplantation?
| S-EPMC11229429 | biostudies-literature
Unknown Novel Biomarkers for Outcome After Allogeneic Hematopoietic Stem Cell Transplantation.
| S-EPMC7461883 | biostudies-literature
Unknown Microbiome-based prediction of allogeneic hematopoietic stem cell transplantation outcome.
| S-EPMC12273375 | biostudies-literature
Unknown Hypomethylating Agents and FLT3 Inhibitors As Maintenance Treatment for Acute Myeloid Leukemia and Myelodysplastic Syndrome After Allogeneic Hematopoietic Stem Cell Transplantation-A Systematic Review and Meta-Analysis.
| S-EPMC9533376 | biostudies-literature
Unknown Proteomics to predict relapse in patients with myelodysplastic neoplasms undergoing allogeneic hematopoietic cell transplantation.
| S-EPMC10809608 | biostudies-literature
Unknown Hypomethylating agents after allogeneic blood stem cell transplantation.
| S-EPMC5182210 | biostudies-literature
Unknown Anti-PD-1 combined with hypomethylating agent and CAG regimen bridging to allogeneic hematopoietic stem cell transplantation: a novel strategy for relapsed/refractory acute myeloid leukemia.
| S-EPMC11361969 | biostudies-literature